Johnson & Johnson names Tom Cavanaugh EVP, worldwide chairman of Innovative Medicine as Taubert retires

Reuters2026/08/04 12:45

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Johnson & Johnson EVP Jennifer Taubert will retire as worldwide chairman of Innovative Medicine following a 21-year tenure.
Tom Cavanaugh will succeed Taubert as EVP, worldwide chairman of Innovative Medicine effective Sept. 1, 2026.
Cavanaugh currently serves as company group chairman, North America, Innovative Medicine.
He joined the company in 2017, holding senior leadership roles in oncology, immunology, global commercial strategy.
Before joining, he spent nearly 15 years at Celgene across product development, medical affairs, marketing, regional management in Spain, the U.S.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via Business Wire (Ref. ID: 202608040845BIZWIRE_USPR_____20260804_BW327747) on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Johnson & Johnson names Tom Cavanaugh EVP, worldwide chairman of Innovative Medicine as Taubert retires

You may also like

Crypto prices